Compass Therapeutics is a fully-integrated drug discovery and development company focused on manipulating the immune system to treat human disease using our proprietary Targeted Immunomodulation™ platform. Compass is initially focused on developing cures for cancer by comprehensively drugging the entire tumor-immune synapse with combination therapies. Novel scientific insights are validated and explored deeply inside our labs before Compass pursues the best proprietary combinations of therapeutics into human clinical trials.
Compass has attracted $170M in Series A financing to fund our ambitious plan to build a fully- integrated biopharmaceutical company from the ground up. Our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value through our therapeutic pipeline. They include OrbiMed Advisors, F-Prime Capital, Borealis Ventures, Thiel Capital, Cowen Private Investments, GV, and Alexandria Real Estate Ventures.
Our Translational Immunology and Immunopharmacology group is seeking a Senior/Principal Scientist, Innate Cellular Immunpharmacology to work hands-on at our Cambridge, MA site.
We believe that science is bigger than any one person. Our legacy is what we achieve together. To that end, Compass Therapeutics offers individually-tailored compensation packages which include competitive cash compensation, meaningful equity participation, comprehensive healthcare and adoption benefits, continuous career development, sabbatical programs, education reimbursement and many other benefits aligned with our philosophy of putting our team first. Our labs are located at 245 First Street, Cambridge, MA.